Home > Boards > US Listed > Medical - Drugs > Allergan (AGN)

$AGN Update on their move to protect patent

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
KarinCA Member Profile
Member Level 
Followed By 540
Posts 24,538
Boards Moderated 2
Alias Born 11/16/07
160x600 placeholder
Ironwood & Allergan Report Positive Topline Data from Phase IIIb Trial of LINZESS® (linaclotide) in Adults with Irritable Bo... Business Wire - 6/18/2019 4:05:00 PM
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) - 6/17/2019 5:02:19 PM
FDA Approves Amgen And Allergan's KANJINTI™ (trastuzumab-anns), A Biosimilar To Herceptin® (trastuzumab) PR Newswire (US) - 6/13/2019 7:13:00 PM
Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar... PR Newswire (US) - 5/28/2019 7:30:00 AM
Allergan Announces Updated Presentation Time at the Bernstein Strategic Decisions Conference PR Newswire (US) - 5/24/2019 4:05:00 PM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 5/23/2019 4:18:09 PM
Allergan to Present at the Jefferies 2019 Healthcare Conference PR Newswire (US) - 5/23/2019 7:30:00 AM
Allergan Expands PLEDGE Clinical Research Program in Diabetic Gastroparesis PR Newswire (US) - 5/17/2019 7:30:00 AM
Allergan to Present at the Bernstein Strategic Decisions Conference PR Newswire (US) - 5/16/2019 7:30:00 AM
Allergan to Present VRAYLAR® (cariprazine) Data at the American Psychiatric Association (APA) 2019 Annual Meeting Highlighti... PR Newswire (US) - 5/15/2019 7:30:00 AM
PatientFi® Announces Study Partnership with Allergan Business Wire - 5/15/2019 6:00:00 AM
Allergan to Present at the Bank of America Merrill Lynch 2019 Health Care Conference PR Newswire (US) - 5/9/2019 7:30:00 AM
Takeda Sells Eye Drug to Novartis -- WSJ Dow Jones News - 5/9/2019 3:02:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2019 5:29:05 PM
Allergan Reports First Quarter 2019 Financial Results PR Newswire (US) - 5/7/2019 7:00:00 AM
Medicines360 and Allergan Present Six-Year Clinical Data from Largest Ongoing Phase 3 Study of an Intrauterine System in the ... PR Newswire (US) - 5/6/2019 8:50:00 AM
Allergan Declares Second Quarter 2019 Cash Dividend of $0.74 Per Ordinary Share PR Newswire (US) - 5/3/2019 7:45:00 AM
Allergan to Present Two Podium Presentations on Bimatoprost Sustained-Release (SR) at The American Society of Cataract and Re... PR Newswire (US) - 5/3/2019 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:52:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:51:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:49:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:46:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:46:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:43:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/2/2019 4:41:49 PM
KarinCA Member Level  Friday, 03/16/18 01:22:38 PM
Re: KarinCA post# 139
Post # of 186 
$AGN Update on their move to protect patent from IPR process by giving it to St Regis Mohawk Tribe. The PTAB decided to deny the motion to terminate the proceedings.
https://www.patentprogress.org/wp-content/uploads/2018/02/PTAB-Denial-Of-Sovereign-Immunity-In-Allergan-IPRs.pdf

Allergan and the St. Regis Mohawk Tribe are fighting it.
https://www.jdsupra.com/legalnews/st-regis-mohawk-tribe-and-allergan-file-74636/





To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist